Planning To Invest in Divi’s Lab, Suzlon, Venus Remedies? #AskBQ
#AskBQ | Expert Advice on Divi’s Lab, Suzlon and Venus Remedies
#AskBQ is BloombergQuint’s daily offering where market experts help investors make the right investment choice — be it in equities, commodities or the derivatives markets.
On Friday’s episode, Rakesh Bansal, vice president at RK Global and Hemen Kapadia of KR Choksey Shares gave their views on Divi’s Lab, Suzlon, Venus Remedies and many more.
Watch the discussion here:
Here are the edited excerpts of the interview:
Monty Sharma: I bought 500 shares of Divi’s Lab at Rs 880 with a short-term view. Should I hold or sell?
Hemen Kapadia: I would advice you to sell.
Rakesh Bansal: I would advise you to hold with a stoploss at Rs 830. If Rs 890 is taken out on upside, then Rs 935 is the likely target.
Suhas Vyas: Bought 100 shares of ITC at Rs 385 with a one year view. Should I hold or sell?
Hemen Kapadia: I would advice you to hold.
Hemen Kapadia: I would advise you to hold and average around Rs 255. Rs 245-250 is the strong support zone and one year conservative target is above Rs 325.
Anil Jaykar: I want to invest Rs 20,000 in the market with a long-term view. Please advise.
Hemen Kapadia: I would advice you to buy Reliance Industries on declines.
Rakesh Bansal: I would advise you to buy in companies like Sundram Fastener, Borosil Glass and Navkar Corp.
Chintan: I bought 1,400 shares of Aurionpro Solutions at Rs 150 with a six month view. Should I hold or sell?
Hemen Kapadia: I would advice you to hold.
Rakesh Bansal: I would advise you to hold with a six-month target of Rs 175. Strong support seen at Rs 130.
Aryan Rana: I bought 100 shares of Venus Remedies with a three-month view. Should I hold or sell?
Hemen Kapadia: I would advice you to hold.
Rakesh Bansal: I would advise you to switch to companies like Shilpi Medicare or Cipla.
Abhishek Agrawal: I want to invest in Graphite India with a long-term view. Please advise.
Hemen Kapadia: I would advise you to buy on declines.
Rakesh Bansal: I would advise you to either add on declines or buy Sundram Fastener for a target of Rs 1,100 in two-years.
Sunil Jain: I want to invest in HFCL with a long-term view. Please advise.
Hemen Kapadia: It is a high risk buy.
Rakesh Bansal: I would advise you to avoid and suggest you to buy KM Sugar for target of Rs 35-37 in six to eight months and target of Rs 50 in 18-24 months.
Raj Shah: I bought 500 shares of Bhansali Engineering at Rs 83. Should I hold or sell?
Hemen Kapadia: I would advice you to hold.
Rakesh Bansal: I would advise you to book profit around Rs 125-135.
Abhinandan: I bought 2,000 shares of Suzlon at Rs 24.45 with a long-term view. Should I hold or sell?
Hemen Kapadia: I would advice you to hold.
Rakesh Bansal: Same.
Gagan Maheshwari: I want to invest in Kalyani Steel with a short-term view. Please advise.
Hemen Kapadia: I would advise you to invest with a stoploss of Rs 389
Rakesh Bansal: I would advise you to buy only if you have a view of at least one-year. One-year target is Rs 500
Allen Ved: I bought 100 shares of Techno Electric at `346 with a 1-year view. Should I hold or sell ?
Hemen Kapadia: I would advice you to hold.
Rakesh Bansal: I would advise you to hold with support of Rs 290. One year target is Rs 400.
Hemachandra Srinivasappa: I want to invest in Fedders Electric & Engineering with a long-term view. Please advise
Hemen Kapadia: I would advice you to buy.
Rakesh Bansal: I would advise you to buy with one-year target of Rs 109 and support of Rs 60.
Here’s how you can get your queries answered:
- Tweet us your using #AskBQ
- WhatsApp us on +91-8291229686
- Call us on 022-45404141
- Email us on askbq@bloombergquint.com
Analysts’ Disclosure:
Hemen Kapadia: I have no financial interests but some of my relatives may own some of the stocks discussed.
Rakesh Bansal: I have no financial interests and do not hold any stocks discussed.
Disclaimer: The commentary and advice on BloombergQuint’s digital and social media platforms is not a full financial plan. Investors are advised to consult a certified financial advisor/planner when making an independent decision regarding investments. No views mentioned on the programme is personal advice to anyone.
Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.
BloombergQuint’s digital and social media platforms provide views of only SEBI registered investment advisors/analysts.